Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. (Q48260531)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. |
scientific article |
Statements
1 reference
Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. (English)
1 reference
P B Jeppesen
1 reference
M Pertkiewicz
1 reference
L Pironi
1 reference
S M Gabe
1 reference
F Joly
1 reference
B Messing
1 reference
S Loth
1 reference
N N Youssef
1 reference
H Heinze
1 reference
P Berghöfer
1 reference
28 March 2013
1 reference
1 reference
32
1 reference
5
1 reference
713-721
1 reference
Identifiers
1 reference
1 reference